Mergers & Acquisitions - Pharmaceutical, Dermatologicals

Filter

Popular Filters

1 to 25 of 26 results

Stada Arz acquires Flexitol rights for UK and Ireland

Stada Arz acquires Flexitol rights for UK and Ireland

10-07-2014

Thornton & Ross, the UK subsidiary of German generic and branded drugmaker Stada Arzneimittel, has purchased…

DermatologicalsFlexitolIrelandMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & RossUK

FTC puts conditions on Valeant’s acquisition of Precision Dermatology

FTC puts conditions on Valeant’s acquisition of Precision Dermatology

04-07-2014

Canada’s Valeant Pharmaceuticals International and its takeover target Precision Dermatology have agreed…

ActavisDermatologicalsMatawan PharmaceuticalsMergers & AcquisitionsPharmaceuticalPreCision DermatologyRegulationValeant Pharmaceuticals International

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

28-05-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceuticalValeant Pharmaceuticals

Aqua’s acquisition to push Almirall in US dermatology market

03-04-2014

Spain’s largest drugmaker, Almirall (ALM: MC), announced at the end of last year the acquisition of…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

31-03-2014

Hong Kong-listed Lansen Pharmaceutical has acquired the pharmaceutical product, marketed and sold in…

Asia-PacificChinaDermatologicalsLansen PharmaceuticalMergers & AcquisitionsNovartisPharmaceuticalSicorten

Nestle takes full control of Galderma Pharma

19-02-2014

The boards of Switzerland-based Nestle, the world’s largest food company, and French cosmetics firm…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceutical

Valeant spending $475 million to boost dermatology portfolio

Valeant spending $475 million to boost dermatology portfolio

03-02-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into a definitive agreement…

DermatologicalsMergers & AcquisitionsPharmaceuticalPreCision DermatologyValeant Pharmaceuticals

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio

03-01-2014

US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

Everett Labs acquires Quinnova Pharma to diversify US market presence

27-12-2013

US specialty pharma firm Everett Laboratories, a subsidiary of Spain’s Exeltis, has acquired Quinnova…

Amneal EnterprisesDermatologicalsEverett LaboratoriesExeltisMergers & AcquisitionsNorth AmericaPharmaceuticalQuinnova PharmaceuticalsUSAWomen's Health

Almirall to acquire US dermatology firm for $305 million upfront

Almirall to acquire US dermatology firm for $305 million upfront

17-12-2013

Spain’s largest drugmaker, Almirall says it has reached a definitive agreement to acquire Aqua Pharmaceuticals,…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Aqua Pharma acquires Verdeso Foam from GSK

05-06-2013

West Chester-based, USA, Aqua Pharmaceuticals says it has acquired the US rights to, and re-launch of,…

Aqua PharmaceuticalsDermatologicalsGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVerdeso

Valeant to acquire Obagi Medical for around $344 million

20-03-2013

Canada-based Valeant Pharmaceuticals International (TSX: VRX) is on the acquisition trail again, announcing…

DermatologicalsMergers & AcquisitionsObagi Medical ProductsPharmaceuticalValeant Pharmaceuticals

Allergan to acquire SkinMedica business for $350 million

18-11-2012

US drug firm Allergan (NYSE: AGN), best known as the maker Botox (onabotulinumtoxinA) anti-wrinkle injections,…

AllerganDermatologicalsMergers & AcquisitionsPharmaceuticalSkinMedica

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million

09-11-2012

India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion

04-09-2012

In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada's Valeant…

DermatologicalsMedicis PharmaceuticalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

US FTC puts conditions on Novartis buy of Fougera

17-07-2012

The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalTolmar

Suneva Medical acquires product portfolio from Spear Pharma

24-05-2012

Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from…

DermatologicalsGenericsMergers & AcquisitionsPharmaceuticalRefissaSpear PharmaceuticalsSuneva MedicalTretinoin

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

Maruho boosts US presence with Cutanea acquisition

15-02-2012

Japan’s Maruho says it has acquired Cutanea Life Sciences (CLS), a privately held dermatology development…

Cutanea Life SciencesDermatologicalsMaruhoMergers & AcquisitionsPharmaceutical

FTC stipulates divestments for Valeant acquisitions

14-12-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

USA’s SOHM acquires Novatrend to expand presence in India

28-11-2011

California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Pfizer to buy Excaliard, gaining rights to Ph II skin scarring product

23-11-2011

Global pharma behemoth Pfizer (NYSE: PFE) says it has entered into a definitive agreement to acquire…

DermatologicalsExcaliard PharmaIsis PharmaceuticalsMergers & AcquisitionsPfizerPharmaceutical

1 to 25 of 26 results

Back to top